Abstract:Fish oil (FO) is a commonly used supplemental source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), 2 n–3 (v-3) polyunsaturated fatty acids (PUFAs) that have been shown to have a variety of health benefits considered to be protective against cardiometabolic diseases. Although the effects of EPA and DHA on lipid metabolism have been extensively studied, not all of the metabolic effects of FO-derived n–3 PUFAs have been characterized. Our laboratory recently showed that a high-fructose diet in rhesusmonkeys induces the features of metabolic syndrome (MetS) similar to those observed in humans. Thus, we specifically wanted to evaluate the effects of FO in rhesus monkeys fed a highfructose diet and hypothesized that FO supplementation would mitigate the development of fructose-induced insulin resistance, dyslipidemia, and other cardiometabolic risk factors. In this study, adult monkeys (aged 12–20 y) received either a standard unpurified diet plus 75 g fructose/d (control group; n = 9) or a standard unpurified diet, 75 g fructose/d, and 4 g FO (16% EPA 1 11% DHA)/d (treatment group; n = 10) for 6 mo. Importantly, our results showed that daily FO supplementation in the monkeys prevented fructose-induced hypertriglyceridemia and insulin resistance as assessed by intravenous-glucose-tolerance testing (P # 0.05). Moreover, FO administration in the monkeys prevented fructoseinduced increases in plasma apolipoprotein (Apo)C3, ApoE, and leptin concentrations and attenuated decreases in circulating adropin concentrations (P# 0.05). No differences between the control and FO-treatedmonkeyswere observed in body weight, lean mass, fat mass, or fasting glucose, insulin, and adiponectin concentrations. In conclusion, FO administration in a nonhuman primate model of diet-induced MetS ameliorates many of the adverse changes in lipid and glucose metabolism induced by chronic fructose consumption. J. Nutr. 144: 5–11, 2014.

Synthesis, characterization, DNA binding properties and antioxidant activity of Ln(III) complexes with hesperetin-4-one-(benzoyl) hydrazone.

Synthesis, Characterization, and DNA-binding of Ln(III) Complexes with 2-Hydroxybenzylidene-2-phenylquinoline-4-carbonylhydrazone

Synthesis, characterization, DNA binding properties, fluorescence studies and antioxidant activity of transition metal complexes with hesperetin-2-hydroxy benzoyl hydrazone

Synthesis, characterization, antioxidant activity, and DNA-binding studies of 1-cyclohexyl-3-tosylurea and its Nd(III), Eu(III) complexes

Synthesis, Characterization, Dna-Binding Studies of Rare Earth Complexes with N-Phenyl Norcantharidin Acylamide Acid

Synthesis, Characterization and DNA Binding of the Complexes of Rare Earth with Phenanthroline and Demethylcantharate

Synthesis, Characterization and Biological Activity of Rare Earth Complexes of 1-Phenyl-3-methyl-5-hydroxy-4-pyrazolyl Phenyl Ketone Isonicotinoyl Hydrazone

DNA Binding Properties of Sc(III) Complexes Derived from Rare-earth(iii) Ions and Semicarbazone of 8-Hydroxyquinoline-2-carbaldehyde

Lanthanide (III) complexes (Ln = Er and Yb) based on polypyridyl ligand: Synthesis, crystal structure, DNA-binding activity and interaction with human serum protein in vitro

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Synthesis, spectral properties, DNA binding interactions and DNA cleavage studies of lanthanide (III) complexes of 2-acetylpyridine acetoylhydrazone: the X-ray crystal structure of 10-coordinate Ce (III) and Sm (III) complexes

Three water-soluble acylhydrazone tetranuclear transition metal complexes: Crystal structures, DNA/BSA interactions and cytotoxicity studies

Construction of three novel Ln 3 compounds using multidentate Schiff base ligand: crystal structures, fluorescence properties, and biological activities

Synthesis, characterization and cytotoxicity of lanthanum(III) complexes with novel 1,10-phenanthroline-2,9-bis-α-amino acid conjugates

Crystal Structure, Fluorescence Properties, and Biological Activity of Three Butterfly-shaped Ln4 Compounds

Synthesis, cytotoxicity and DNA binding of novel Ni(II), Co(II) and Zn(II) complexes bearing pyrimidinyl hydrazone ligand

Synthesis, crystal structures and thermal decomposition kinetics of four new lanthanide complexes with 3,4-dimethylbenzoic acid and 1,10-phenanthroline

Fish Oil Supplementation Ameliorates Fructose-Induced Hypertriglyceridemia and Insulin Resistance in Adult Male Rhesus Macaques 1 , 2

A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity.

Synthesis, Thermodynamic Properties and Antibacterial Activities of Lanthanide Complexes with 3,5-Dimethoxybenzoic Acid and 1,10-Phenanthroline

Synthesis and Magnetic Characterization of Ln(III)–Co(II) Complexes with 1,10-Phenanthroline Ligands